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For many years nebulized isoprenaline solutions have proved useful in the treatment of asthmatic children admitted with severe bronchoconstriction. Their use gives the child some relief from his symptoms but almost always is accompanied by tachycardia, and may actually cause a fall in arterial Po2 by augmenting ventilation/perfusion mismatch (Palmer and Diament, 1967) .
Three bronchodilators-isoprenaline, orciprenaline, and salbutamol-were investigated to see which produced most relief of bronchospasm with least cardiac disturbance.
Subjects
The 12 children (6 boys and 6 girls) all attended the asthma clinic of The Hospital for Sick Children. Their ages ranged from 10 years 6 months to 14 years 4 months, with a mean of 11 years 9 5 months. All the children had had symptoms of asthma for over 7 years, and 10 had been on steroids for at least 6 months at some time. At the time of the trial 3 were on steroids and 11 were on disodium cromoglycate, with or without isoprenaline (Intal co. and Intal). Six of the children were below the 3rd centile for height.
Procedure
Each child attended on four occasions. The visits tended to be at irregular intervals but each child was kept to a morning or afternoon session to reduce errors from fluctuations in airways resistance during the day (Lewinsohn, Capel, and Smart, 1960 asked not to give the child any bronchodilator or isoprenaline on the day of the test but steroids were not discontinued.
On arrival, lung function was assessed from measurements of the forced vital capacity (FVC) and the forced expiratory volume over 0 75 sec (FEVO.75) using a reverse plethysmograph. The FEVo.75 was measured rather than the FEV1.0 because some young healthy children are able to breathe out their FVC in 1 second (Lunn, 1965) . The reverse plethysmograph consists of a rigid container, volume 1,500 litre (Fig. 1) (Quenouille, 1953 period of the investigation as judged by the FVC, but the total effect of salbutamol, as measured by integration of the area under the curve, was significantly larger than the placebo.
2. Cardiac effects of drugs. All four solutions were followed by an increase in the pulse rate (Fig. 4) . This was very small after the placebo (+3%) and relatively small after salbutamol (+13%) but was significantly larger after isoprenaline (+29%) than after salbutamol and placebo, and significantly larger after orciprenaline (+26%) than after the placebo (Table III) longer than after isoprenaline. Orciprenaline had the largest effect on the heart rate as judged by the 'area under the curve', but this only reached significance when compared to placebo (Table III) .
Only the placebo solution produced no rise in systolic blood pressure (Fig. 5 ) but the effect of salbutamol was slight. Isoprenaline and orciprenaline were both followed by significant increases compared to the placebo solution (Table IV and V) . Orciprenaline again had the largest total effect.
As regards diastolic pressure, only isoprenaline had an appreciable effect, causing a 13% increase.
Order of drug administration. The results were also examined to see whether there was any difference in the cardiovascular and bronchodilator response between the first and subsequent sessions, as it was felt that on the initial visit the Grant (1969) , Choo-Kang, Simpson, and Grant (1969) , Kamburoff and Prime (1970) , and Riding, Dinda, and Chatterjee (1970) , with normal and asthmatic adults, found that dose for dose salbutamol was several times more potent than isoprenaline. However, Warrell et al. (1970) , using more sophisticated techniques, obtained very similar response curves for the two drugs, and Riding, Chatterjee, and Dinda (1969) found very similar relief of bronchoconstriction in asthmatic adults after the inhalation of 0 * 5% salbutamol and 0-5 % isoprenaline delivered by an ultrasonic nebulizer. Hambleton and Shinebourne (1970) reported that 100 [±g doses of isoprenaline and salbutamol delivered as an aerosol produced very similar relief of airways obstruction in 10 children with asthma, but that the effect of salbutamol was more prolonged. When compared to salbutamol, orciprenaline was less effective in relieving bronchospasm even with six times the dose (Kennedy and Simpson, 1969) , but it was not felt justified to exceed the relatively high concentration of 2 5% in these children. Our The cardiac effects of the drugs showed greater variation. As was expected, isoprenaline caused an increase in heart rate of up to 70 %; in only two children was the increase less than 20%. The effect on the cardiovascular system was also reflected in the increase in systolic and diastolic pressure. Rather more surprising was the tachycardia and increase in systolic blood pressure associated with the orciprenaline. These changes persisted for longer than the changes after isoprenaline. Salbutamol did produce an increase in the heart rate which persisted for significantly longer than after isoprenaline, but the increase was much less marked than after the other two drugs. Riding et al. (1969) found a similar rise in the pulse rate after the inhalation of a nebulized solution of 0-5% in adults. However, Kennedy and Simpson (1969) found no change in pulse and blood pressure after the inhalation of 400 ,ug salbutamol from an aerosol, and Riding et al. (1970) actually observed a fall after 200 .tg.
It is possible that a similar degree of bronchodilatation could have been achieved with a considerably lower dose, but we were anxious to reproduce the doses likely to be given to a child admitted to the ward in severe bronchospasm. In conclusion, a 0 * 5% salbutamol solution delivered by a Wright nebulizer is as effective a bronchodilator agent as 0 5% isoprenaline or 2 5 % orciprenaline, but had considerably less effect on the cardiovascular system and thus should be used in place of isoprenaline for children with severe bronchoconstriction.
